Malignant Pancreatic Neoplasm: A primary or metastatic malignant tumor involving the pancreas. Representative examples include carcinoma and lymphoma. -- 2003
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1111 |
4. Check minimum number of eventsNone |
1111 |
5. Include endpointsNone |
1111 |
6. Filter based on genotype QC (FinnGen only) |
1033 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D13
- Name in latin
- Neoplasma benignum pancreatis
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Pancreas
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm of other and ill-defined parts of digestive system
- Benign neoplasms
- Neoplasms
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4049 | 2363 | 1645 |
| Only index persons | 3590 | 2126 | 1464 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.06 | 0.07 | 0.05 |
| Only index persons | 0.07 | 0.08 | 0.06 |
| Median age at first event (years) | |||
| Whole population | 69.61 | 70.03 | 69.18 |
| Only index persons | 69.51 | 69.68 | 69.25 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1033 | 592 | 441 |
| Unadjusted period prevalence (%) | 0.21 | 0.21 | 0.20 |
| Median age at first event (years) | 69.81 | 68.92 | 71.00 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1049
- Matched controls
- 10490
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
25.7
307.7
254
129
K86.2
ICD-10 Finland
Cyst of pancreas
51.0
307.7
219
54
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
64.8
307.7
488
139
D13.6
ICD-10 Finland
Benign neoplasm: Pancreas
4503599627370496.0
307.7
1038
*
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
22.6
245.9
189
101
A09AA02
ATC
multienzymes (lipase, protease etc.); oral
17.7
210.8
182
123
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
18.4
206.5
174
112
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
21.6
176.4
136
72
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
60.0
174.6
98
18
JLC30
NOMESCO Finland
Pancreatoduodenectomy
39.9
143.1
88
24
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
22.2
114.7
86
42
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
27.5
114.6
79
31
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
41.8
103.9
63
16
JN3AD
NOMESCO Finland
Abdominal CT examination
4.5
99.8
317
924
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
23.8
95.0
69
31
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
18.6
84.1
68
39
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
13.2
76.9
75
61
WZC30
NOMESCO Finland
Teaching
3.6
74.5
336
1223
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
13.4
71.5
69
55
UJK02
NOMESCO Finland
ERCP
7.9
69.3
99
136
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
10.0
68.9
81
87
WX302
NOMESCO Finland
Thoracal epidural anesthesy
5.4
68.6
148
309
JLC10
NOMESCO Finland
Distal pancreatectomy
108.7
65.7
71
7
JLC11
NOMESCO Finland
Laparoscopic distal pancreatectomy
308.5
57.9
58
*
R10.1
ICD-10 Finland
Pain localized to upper abdomen
3.1
56.7
322
1319
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.7
53.5
505
2688
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
13.8
52.2
49
37
RD211, ,
NOMESCO Finland
5.2
51.2
112
235
K86.9
ICD-10 Finland
Disease of pancreas, unspecified
20.2
50.4
39
20
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.2
50.0
145
382
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
5.6
47.5
94
180
JMA10
NOMESCO Finland
Transabdominal total splenectomy
19.1
46.7
37
20
Z71.8
ICD-10 Finland
Other specified counselling
2.5
46.7
474
2570
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
43.5
452
2457
K83.0
ICD-10 Finland
Cholangitis
9.4
42.8
52
58
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
10.6
41.6
46
45
ZYC01
NOMESCO Finland
Remote contact by phone
4.0
41.2
126
344
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.3
40.9
173
586
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
3.7
37.1
126
369
K86.1
ICD-10 Finland
Other chronic pancreatitis
11.2
35.7
38
35
JN4AD
NOMESCO Finland
Body CT examination
2.8
35.2
219
918
K83.1
ICD-10 Finland
Obstruction of bile duct
7.5
35.0
51
71
R4190
NOMESCO Finland
Nutritional therapy
4.8
34.9
82
182
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
7.5
33.7
49
68
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
3.4
33.6
136
446
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
7.0
33.4
52
78
K85.8
ICD-10 Finland
Other acute pancreatitis
13.2
33.3
32
25
Z3231
NOMESCO Finland
Registered nurse
2.3
32.7
373
2057
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.9
32.4
172
661
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.6
31.1
211
919
D13.7
ICD-10 Finland
Benign neoplasm: Endocrine pancreas
70.1
30.1
34
5
ZX120
NOMESCO Finland
Intravenous
2.9
29.5
160
620
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
7.3
27.7
41
58
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
9.7
27.2
32
34
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
6.6
26.2
43
68
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.2
25.9
112
381
JAH01
NOMESCO Finland
Laparoscopy
3.8
25.8
81
224
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
55.3
23.1
27
5
D13.2
ICD-10 Finland
Benign neoplasm: Duodenum
9.5
22.7
27
29
B01AB10
ATC
tinzaparin; parenteral
2.4
22.0
174
806
R50.9
ICD-10 Finland
Fever, unspecified
2.3
21.8
201
993
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
8.3
21.8
29
36
N02AX02
ATC
tramadol; systemic, rectal
1.9
21.4
527
3682
A05AA02
ATC
ursodeoxycholic acid; oral
6.7
21.4
34
52
A02BC02
ATC
pantoprazole; systemic
2.0
20.4
799
6434
UJF32
NOMESCO Finland
Coloscopy
1.9
20.3
354
2206
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
2.3
19.5
165
784
130
Kela drug reimbursment
Malignant tumour
2.4
19.5
142
632
JN4CD
NOMESCO Finland
Very extensive body CT
3.3
18.6
71
223
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
5.4
18.3
36
68
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
13.9
18.3
31
23
K86.8
ICD-10 Finland
Other specified diseases of pancreas
19.8
18.2
27
14
WX402
NOMESCO Finland
General anaesthesia
1.9
18.1
273
1611
XX2RW, ,
NOMESCO Finland
5.6
18.0
34
62
B01AB05
ATC
enoxaparin; parenteral
1.8
17.9
405
2715
K86.3
ICD-10 Finland
Pseudocyst of pancreas
15.9
17.6
28
18
Z25.1
ICD-10 Finland
Need for immunization against influenza
2.9
17.1
82
295
TPH07
NOMESCO Finland
Cathetrisation of artery
2.1
16.6
169
863
Z00.0
ICD-10 Finland
General medical examination
1.9
16.3
247
1455
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
16.2
279
1711
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
2.2
15.8
148
731
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.0
15.7
71
247
C25.4
ICD-10 Finland
Malignant neoplasm: Endocrine pancreas
86.4
15.6
17
*
Z13.1
ICD-10 Finland
Special screening examination for diabetes mellitus
4.2
15.5
41
100
A03FA01
ATC
metoclopramide; systemic, rectal
1.8
15.2
277
1725
SPAT1359
SPAT
Use of symptom diary
3.9
15.1
45
120
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
3.6
14.9
49
140
R4110
NOMESCO Finland
Physiotherapy
1.7
14.6
336
2236
A10AE04
ATC
insulin glargine; parenteral
2.2
14.3
132
647
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.1
14.3
146
745
WZC00
NOMESCO Finland
Treatment plan or consultation
1.7
14.2
421
2995
T90
ICPC
Diabetes non-insulin dependent
1.7
14.2
322
2132
XX3DW
NOMESCO Finland
Time consuming IT work
2.1
14.0
155
814
R93.3
ICD-10 Finland
Abnormal findings on diagnostic imaging of other parts of digestive tract
11.1
14.0
26
24
HMAK, ,
NOMESCO Finland
2.2
13.9
133
662
8240/3-C25.9
ICD-O-3
Neuroendocrine tumor, NOS, of pancreas, NOS
54.1
13.8
16
*
N02BE01
ATC
paracetamol; systemic, rectal
2.5
13.8
974
8794
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.7
13.8
315
2086
C25.1
ICD-10 Finland
Malignant neoplasm: Body of pancreas
13.8
13.8
23
17
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.7
13.5
312
2069
A10AB05
ATC
insulin aspart; parenteral
2.3
13.3
102
462
103
Kela drug reimbursment
Diabetes, insulin-treated
1.7
13.2
332
2253
JLW98
NOMESCO Finland
Other transluminal endoscopic operation on pancreas
40.6
13.2
16
*
JAH00
NOMESCO Finland
Laparotomy
3.5
13.1
46
137
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.0
13.0
148
785
J01MA02
ATC
ciprofloxacin; systemic
1.6
12.9
437
3197
C25.2
ICD-10 Finland
Malignant neoplasm: Tail of pancreas
15.7
12.6
20
13
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.8
12.6
65
244
JL5AM
NOMESCO Finland
Bile and pancreas ducts simple MRI examination with 3 Tesla magnet
+∞
12.5
12
*
JN1CM
NOMESCO Finland
Upper part of abdomen extensive MRI examination with 3 Tesla magnet
20.3
12.5
18
9
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.7
12.4
296
1973
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
2.2
12.4
105
496
-1, ,
NOMESCO Finland
1.7
12.4
330
2265
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.0
12.2
55
191
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
4.6
12.2
29
65
UJK12
NOMESCO Finland
Peroral cholangioscopy
47.2
11.9
14
*
K85
ICD-10 Finland
Acute pancreatitis
4.2
11.8
31
75
J01MA12
ATC
levofloxacin; systemic
1.8
11.7
221
1380
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.6
11.7
333
2321
C25.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of pancreas
19.2
11.6
17
9
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.0
11.6
137
736
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.7
11.5
246
1587
K85.0
ICD-10 Finland
Idiopathic acute pancreatitis
10.2
11.5
22
22
UJK42
NOMESCO Finland
Peroral pancreaticoscopy
121.3
11.4
12
*
8140/3-C25.9
ICD-O-3
Adenocarcinoma, NOS, of pancreas, NOS
9.0
11.3
23
26
R53
ICD-10 Finland
Malaise and fatigue
1.7
11.2
277
1859
D13.9
ICD-10 Finland
Benign neoplasm: Ill-defined sites within the digestive system
20.3
11.1
16
8
SPAT1252
SPAT
Overall medication plan or its review
2.2
11.1
96
458
PLAK1, ,
NOMESCO Finland
5.5
10.9
21
39
TQW80
NOMESCO Finland
Local dermatologic skincare
3.3
10.9
40
123
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
4.0
10.8
30
76
D02
ICPC
Abdominal pain epigastric
2.3
10.8
80
358
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.1
10.7
103
513
J01DB01
ATC
cefalexin; oral
1.7
10.6
857
7557
GD1AA, ,
SPAT
1.8
10.4
156
906
SPAT1131
SPAT
Colonoscopy
2.8
10.4
52
192
JLB28
NOMESCO Finland
Endoscopic internal drainage of pancreatic duct
23.6
10.3
14
6
A02BC05
ATC
esomeprazole; systemic
1.5
10.1
445
3401
AN2
HP
Balloon angioplasty, including several vessels
3.1
10.0
41
135
S18
ICPC
Laceration/cut
1.5
10.0
541
4319
D06
ICPC
Abdominal pain localized other
2.1
9.9
100
507
JN7AQ
NOMESCO Finland
Somatostatin receptor SPET med low dose CT
26.3
9.8
13
5
ZXE20
NOMESCO Finland
More than three and less than five hours
1.8
9.8
163
976
XQ848
NOMESCO Finland
Dermatological photography
2.9
9.8
46
164
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
7.5
9.7
22
30
S15
ICPC
Foreign body in skin
2.1
9.7
89
435
CL2S4
NOMESCO Finland
Ocular fundus photography for diabetic retinopathy screening
3.2
9.5
37
118
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
9.5
254
1730
K30
ICD-10 Finland
Functional dyspepsia
1.9
9.4
131
742
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.7
9.4
209
1357
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
2.9
9.4
44
157
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.9
9.2
120
665
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
2.2
9.2
77
363
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
3.2
9.1
35
111
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
3.8
9.1
27
72
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.6
9.1
218
1442
Z51.0
ICD-10 Finland
Radiotherapy session
4.0
9.1
25
63
8000/3-C25.9
ICD-O-3
Neoplasm, malignant of pancreas, NOS
9.1
9.0
18
20
C07AB07
ATC
bisoprolol; oral
1.5
9.0
568
4643
UJF92
NOMESCO Finland
Capsular endoscopy
3.4
8.8
31
93
JLC40
NOMESCO Finland
Total pancreatoduodenectomy
50.4
8.7
10
*
A10BA02
ATC
metformin; oral
1.5
8.7
333
2454
L01BC06
ATC
capecitabine; oral
2.5
8.6
56
236
JL1AT
NOMESCO Finland
Biopsy of pancreas with ultrasound guidance
27.8
8.5
11
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
3.1
8.5
35
116
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
8.5
327
2411
D76
ICPC
Malignant neoplasm pancreas
12.9
8.4
14
11
K81.9
ICD-10 Finland
Cholecystitis, unspecified
4.9
8.4
18
37
ZXC15
NOMESCO Finland
Use of photodynamic technique
3.8
8.4
25
67
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
4.7
8.4
19
41
N02AA05
ATC
oxycodone; systemic
1.6
8.3
228
1555
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
7.6
8.2
18
24
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
3.3
8.1
30
93
JL2AT
NOMESCO Finland
Cytology of pancreas with ultrasound guidance
33.6
8.1
10
*
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
8.1
381
2920
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
8.0
547
4499
EB1HA, ,
SPAT
2.8
7.9
39
143
K02.1
ICD-10 Finland
Caries of dentine
1.4
7.9
557
4602
JN1AE, ,
SPAT
2.9
7.9
37
132
N30.0
ICD-10 Finland
Acute cystitis
1.6
7.9
185
1214
L17
ICPC
Foot/toe symptom/complaint
1.5
7.9
339
2548
SPAT1310
SPAT
Counselling related to known health issue
1.5
7.9
329
2458
OAB71, ,
SPAT
6.2
7.9
20
33
JKE12
NOMESCO Finland
Endoscopic extraction of calculus from bile duct
3.8
7.8
23
61
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
7.8
273
1967
D01
ICPC
Abdominal pain/cramps general
1.8
7.8
129
771
8500/3-C25.0
ICD-O-3
Infiltrating duct carcinoma, NOS, of head of pancreas
45.3
7.7
9
*
R21
ICPC
Throat symptom/complaint
1.6
7.7
173
1122
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
4.4
7.7
19
44
PLAK2, ,
NOMESCO Finland
7.5
7.7
17
23
TJK01
NOMESCO Finland
Laparoscopic cholangiography
4.6
7.7
18
40
RD210, ,
NOMESCO Finland
3.8
7.7
23
62
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
7.6
211
1440
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.0
7.6
80
412
Z08
ICPC
Social welfare problem
4.1
7.6
20
49
R19.8
ICD-10 Finland
Other specified symptoms and signs involving the digestive system and abdomen
3.9
7.6
22
58
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.6
7.5
199
1343
I10
ICD-10 Finland
Essential (primary) hypertension
1.5
7.5
706
6129
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
1.8
7.4
112
652
Z3229
NOMESCO Finland
Other healthcare associate professional
1.9
7.3
94
519
D13.4
ICD-10 Finland
Benign neoplasm: Liver
6.9
7.3
17
25
JLC00
NOMESCO Finland
Excision of lesion of pancreas
+∞
7.3
7
*
8240/3-C25.2
ICD-O-3
Neuroendocrine tumor, NOS, of tail of pancreas
+∞
7.3
7
*
C259, 8148, 2
ICD-O-3
+∞
7.3
7
*
R5110, ,
SPAT
1.8
7.2
113
664
XX1AD
NOMESCO Finland
Other CT-examination
4.5
7.2
17
38
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.5
7.2
277
2030
XKD00
NOMESCO Finland
Uroflowmetry
1.6
7.2
176
1166
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
2.7
7.1
36
134
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
3.0
7.1
30
101
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
8.9
7.1
14
16
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.5
7.0
280
2064
A03FA02
ATC
cisapride; oral, rectal
1.9
7.0
86
467
H02AB09
ATC
hydrocortisone; systemic
3.0
7.0
30
102
J02AC01
ATC
fluconazole; systemic
1.4
7.0
365
2835
J45.8
ICD-10 Finland
Mixed asthma
2.6
6.9
38
148
ZXE00
NOMESCO Finland
One hour or less
1.4
6.9
386
3034
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.7
6.9
138
868
K59.09
ICD-10 Finland
Constipation, unspecified
1.9
6.9
86
470
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
3.1
6.8
28
93
R07.0
ICD-10 Finland
Pain in throat
2.1
6.8
62
303
R1250
NOMESCO Finland
Evaluation of functional capability
2.7
6.7
34
127
OAB50, ,
SPAT
1.8
6.7
99
572
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.8
6.7
105
618
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
7.9
6.6
14
18
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
3.1
6.6
26
84
K80.8
ICD-10 Finland
Other cholelithiasis
3.1
6.6
26
84
R93.2
ICD-10 Finland
Abnormal findings on diagnostic imaging of liver and biliary tract
4.2
6.6
17
41
XG422, ,
SPAT
8.8
6.6
13
15
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
10.1
6.5
12
12
WX004
NOMESCO Finland
Patient-controlled sedation
10.1
6.5
12
12
B01AB04
ATC
dalteparin; parenteral
2.1
6.5
57
274
D64.9
ICD-10 Finland
Anaemia, unspecified
1.7
6.5
128
801
R03BA01
ATC
beclometasone; inhalant
1.6
6.5
140
897
N30.9
ICD-10 Finland
Cystitis, unspecified
2.0
6.5
72
378
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
2.8
6.5
32
118
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
6.2
6.5
16
26
L04AA06
ATC
mycophenolic acid; systemic
3.2
6.5
25
80
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.0
6.5
64
323
A03
ICPC
Fever
1.6
6.4
147
956
SPAT1130
SPAT
Esophagoscopy, gastroscopy and duodenoscopy
2.4
6.4
41
172
EC1VA, ,
NOMESCO Finland
2.2
6.4
53
249
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.8
6.4
94
541
UJF02
NOMESCO Finland
Peroral enteroscopy
7.5
6.4
14
19
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
3.0
6.4
27
91
RF410, ,
NOMESCO Finland
3.8
6.4
19
51
N03AX16
ATC
[U] pregabalin
1.5
6.4
244
1782
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
6.3
170
1149
JN4BD
NOMESCO Finland
Extensive body CT
1.7
6.3
125
783
127
Kela drug reimbursment
Transplant complication
3.6
6.3
20
56
M54.5
ICD-10 Finland
Low back pain
1.4
6.3
364
2867
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
3.3
6.3
23
71
C07AA05
ATC
propranolol; systemic
1.5
6.3
190
1320
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.9
6.3
82
456
8453/2-C25.9
ICD-O-3
Intraductal papillary mucinous neoplasm with high grade dysplasia of pancreas, NOS
+∞
6.3
6
*
U01
ICPC
Dysuria/painful urination
1.8
6.2
88
501
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
6.2
289
2189
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.2
6.2
50
233
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.3
6.2
46
207
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.7
6.2
105
632
GD1AD
NOMESCO Finland
Thorax CT examination
1.9
6.2
81
451
Z3226
NOMESCO Finland
Physiotherapist
1.5
6.1
189
1318
E0000UV, ,
ATC
1.4
6.1
410
3312
SPAT1216
SPAT
Assessment of functional ability
1.5
6.1
179
1236
JK3NB
NOMESCO Finland
Percutaneous transhepatic cholangiography
8.7
6.1
12
14
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
8.7
6.1
12
14
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.4
6.1
41
177
K76.9
ICD-10 Finland
Liver disease, unspecified
3.6
6.1
19
53
L04AD01
ATC
ciclosporin; systemic
3.3
6.0
22
68
Z49.0
ICD-10 Finland
Preparatory care for dialysis
5.2
6.0
17
33
JN1AD
NOMESCO Finland
CT examination of upper part of abdomen
6.1
6.0
15
25
PLAK0, ,
NOMESCO Finland
6.1
6.0
15
25
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
478
241
35.60
307.65
3.6
3.6
35.33
1604.94
u/ml
0.87
438
226
365
455
11.77
291.66
4.6
3.5
89.80
3345.24
u/ml
0.86
331
392
527
1218
7.69
241.68
3.9
4.4
3.04
22.34
ug/l
2.16
434
1005
409
1075
5.60
153.61
3.0
2.2
0.22
0.21
g/l
5.43
396
1002
222
345
7.89
142.27
1.6
1.5
233.24
277.39
ug/g
1.84
166
211
713
3287
4.65
123.84
4.5
2.6
76.98
87.26
u/l
0.17
698
3020
361
1186
4.12
96.23
4.1
2.8
6.34
8.29
umol/l
1.76
324
1056
899
5470
5.50
95.41
11.3
6.9
11.06
11.80
umol/l
1.16
884
5220
79
8
106.70
73.00
3.3
2.8
70.52
41.10
pmol/l
—
64
8
289
985
3.67
70.48
5.1
2.4
227.27
36.59
u/l
1.49
262
820
733
4382
3.23
67.37
21.0
12.2
0.01
0.00
e9/l
0.48
640
3585
794
5010
3.41
65.72
17.0
16.3
1.21
1.28
inr
3.45
716
4169
767
4780
3.25
64.05
8.6
5.3
34.66
35.20
g/l
2.10
753
4496
979
7651
5.19
46.69
15.7
8.7
85.12
80.10
u/l
2.26
967
7231
843
6036
3.02
45.85
7.0
5.2
6.94
6.76
mmol/l
1.84
827
5784
221
885
2.90
39.03
5.1
3.8
1.23
1.23
mmol/l
0.16
209
765
543
3458
2.18
33.31
5.0
3.6
48.62
76.95
e6/l
0.52
459
2703
442
2635
2.17
31.65
6.8
4.2
88.62
88.14
%
0.15
436
2581
480
2992
2.11
30.23
4.6
3.4
0.44
0.46
e6/l
0.05
395
2257
755
5661
2.19
28.19
12.7
9.9
4.40
4.16
e9/l
1.60
687
4922
502
3249
2.05
27.88
4.5
3.3
33.64
33.93
u/l
0.05
487
3062
655
4685
2.06
27.32
3.7
2.9
—
—
estimate
—
0
0
406
2446
2.08
27.31
3.7
2.7
4.94
5.64
e6/l
0.63
382
2250
281
1482
2.22
26.56
7.2
5.7
1.00
1.03
mmol/l
1.57
271
1369
466
2985
2.01
26.15
5.3
4.3
0.00
0.00
estimate
0.78
279
1036
49
89
5.73
26.04
1.7
1.4
—
—
—
0
0
726
5447
2.08
25.84
10.2
7.5
1.21
1.21
mmol/l
0.07
638
4695
307
1702
2.14
25.42
3.5
2.6
2.34
2.28
g/l
0.99
292
1580
904
7470
2.52
24.26
36.8
22.7
13.99
13.77
%
5.12
899
7376
29
32
9.29
23.93
1.8
1.4
2.13
1.76
umol/l
1.55
29
26
323
1874
2.05
23.37
3.9
3.3
0.81
0.82
mmol/l
0.31
308
1766
286
1592
2.10
23.12
3.7
2.7
21.74
22.26
%
0.24
275
1491
49
100
5.09
22.93
1.3
1.2
1.53
1.49
nmol/l
0.07
44
89
54
120
4.69
22.87
1.5
1.3
0.16
0.19
nmol/l
1.02
42
93
415
2698
1.89
21.07
4.6
3.7
0.00
0.03
estimate
0.63
228
885
309
1821
1.99
21.04
3.6
2.7
12.23
12.56
umol/l
0.32
296
1696
32
47
6.99
20.89
1.6
1.3
27.38
29.83
umol/l
0.66
32
42
292
1696
2.00
20.67
2.5
2.0
29.99
29.39
s
1.20
287
1649
57
144
4.13
20.52
1.6
1.3
0.57
13.16
nmol/l
0.50
52
136
89
303
3.12
20.47
2.3
1.7
—
—
—
0
0
171
811
2.32
20.37
3.6
3.1
10.38
10.94
g/l
0.95
152
745
674
5176
1.85
19.35
5.1
4.2
0.00
0.00
estimate
-0.00
283
1114
680
5282
1.82
18.29
5.2
4.2
0.08
0.29
estimate
0.32
272
1075
79
268
3.11
18.26
1.2
1.2
—
—
—
0
0
673
5233
1.80
17.80
5.2
4.2
0.00
4.57
estimate
1.08
291
1149
797
6528
1.92
17.80
6.2
5.1
26.00
2335.29
e6/l
—
7
101
531
3869
1.75
17.48
4.9
4.2
0.00
0.03
estimate
2.91
229
927
64
197
3.39
17.33
4.9
4.6
3.00
2.66
mmol/l
0.38
50
136
548
4047
1.74
17.04
4.7
4.1
36.24
61.53
ng/l
0.73
428
3110
596
4555
1.71
15.94
3.3
2.5
79.50
79.12
nmol/l
0.12
568
4044
631
4914
1.71
15.59
9.0
6.7
1.20
1.21
mmol/l
1.46
614
4529
150
751
2.16
15.47
7.6
8.8
94.51
93.93
%
0.49
150
745
506
3745
1.68
14.88
3.7
3.4
6.61
7.19
mmol/l
2.76
443
3130
344
2295
1.74
14.86
3.8
3.1
2.47
2.46
mmol/l
1.33
317
2081
507
3786
1.66
14.16
4.5
3.7
2.35
2.36
mmol/l
0.15
485
3420
273
1724
1.79
14.16
4.4
3.3
2.21
2.30
e6/l
0.07
160
892
998
9111
2.96
13.92
31.4
18.0
28.90
25.64
mg/l
2.25
917
7622
500
3741
1.64
13.71
4.6
4.2
5.61
8.77
mg/mmol
2.32
347
2303
50
155
3.34
13.41
1.8
2.1
32.04
32.31
pg
0.16
50
155
193
1121
1.88
13.02
4.6
3.5
—
—
—
0
0
106
495
2.27
12.91
2.2
2.2
0.00
0.01
estimate
0.50
66
138
128
646
2.12
12.85
2.9
1.8
1.41
1.54
g/l
0.17
123
594
202
1203
1.84
12.56
7.2
7.6
95.68
95.58
%
0.07
196
1167
561
4406
1.59
11.98
4.5
3.1
122.77
141.50
ug/l
1.60
534
4072
174
1003
1.88
11.95
9.2
7.2
10.01
10.20
mmol/l
0.14
165
966
977
8938
2.36
11.58
31.8
17.8
76.15
76.30
ml/min/173m2
0.09
960
8365
833
7253
1.72
11.25
6.2
4.6
14.40
13.38
mm/h
0.95
803
6731
277
1893
1.63
10.29
2.0
1.5
2.49
2.56
g/l
0.25
211
1101
211
1345
1.71
10.23
7.1
7.4
5.08
5.10
kpa
0.18
206
1298
62
255
2.52
10.02
2.0
1.5
—
—
—
0
0
365
2682
1.55
9.89
3.9
3.0
345.73
347.67
umol/l
0.14
339
2336
143
821
1.86
9.87
3.2
2.8
66.07
63.04
ml/min/173m2
0.47
80
368
21
26
8.22
9.85
1.0
1.1
—
—
—
0
0
309
2196
1.58
9.65
2.0
1.7
1.31
1.38
mg/l
0.13
245
1731
207
1334
1.69
9.59
7.1
7.3
0.74
0.95
mmol/l
0.39
179
1097
60
1289
0.43
9.42
5.8
5.3
32.94
32.71
%
0.05
47
812
708
6033
1.53
9.31
5.0
3.4
69.22
53.18
u/l
2.13
682
5608
315
2276
1.55
9.05
1.9
1.8
475.44
24812064.45
pmol/l
1.90
274
1858
21
30
7.12
9.05
1.0
1.1
—
—
—
0
0
373
2803
1.51
8.90
2.9
2.3
3.30
2.93
mg/l
1.51
344
2410
179
1135
1.70
8.76
2.4
2.2
195.40
127.24
ug/g
1.05
154
892
131
761
1.82
8.68
8.2
8.6
1.16
1.29
%
0.98
131
755
452
3581
1.46
8.08
3.1
3.2
1333.17
1285.00
ng/l
0.09
412
3092
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
74
367
2.09
7.78
2.9
2.5
0.22
0.39
iu/ml
7.58
44
202
123
730
1.78
7.58
8.7
8.8
0.58
0.64
%
0.87
123
725
133
808
1.74
7.56
1.7
1.6
—
—
—
0
0
32
108
3.02
7.55
1.2
1.2
—
—
—
0
0
955
8885
1.84
7.37
9.0
7.1
41.59
39.93
mmol/mol
7.07
932
8253
26
79
3.35
7.28
2.3
2.8
7.74
8.69
mmol/l
0.65
26
79
198
1346
1.58
7.26
4.3
4.3
232.58
250.37
u/l
0.97
191
1280
156
1007
1.65
7.06
3.1
3.2
65.66
66.35
g/l
0.51
149
927
61
292
2.16
7.04
2.5
2.1
92.43
91.17
%
0.16
61
282
39
153
2.61
7.00
1.4
1.3
180.40
168.20
au/ml
—
10
43
43
177
2.49
7.00
1.2
1.3
—
—
—
0
0
50
225
2.28
6.70
6.9
6.1
328.78
264.68
iu/ml
—
9
28
45
195
2.37
6.58
2.3
2.0
4.96
4.61
mmol/24h
0.27
37
170
53
247
2.21
6.55
1.4
1.3
—
—
—
0
0
31
112
2.82
6.52
1.6
1.6
28.77
35.11
ng/l
0.24
31
112
23
70
3.34
6.44
1.0
1.2
—
—
—
0
0
193
1342
1.54
6.35
2.2
2.0
—
—
—
0
0
36
143
2.57
6.33
1.1
1.1
1.58
1.53
g/l
0.27
31
130
812
7337
1.47
6.30
5.0
4.4
15.12
14.98
pmol/l
0.90
767
6668
77
424
1.88
6.06
3.0
4.3
36.47
79.18
mg/l
0.89
69
367
77
424
1.88
6.06
3.0
4.3
37.83
65.73
mg/l
1.22
69
365
25
86
2.95
5.76
1.2
1.1
112.00
104.19
pmol/l
0.34
25
86
323
2537
1.39
5.56
3.3
2.4
—
—
—
0
0
70
387
1.87
5.46
2.8
4.1
1.44
3.67
ratio
1.55
44
226
198
1434
1.47
5.30
2.2
1.9
—
—
—
0
0
247
1867
1.42
5.26
2.1
2.0
—
—
—
0
0
37
163
2.32
5.26
1.2
1.2
321.15
304.83
u/ml
0.08
26
86
168
1184
1.50
5.15
5.8
3.4
5.89
5.83
kpa
0.29
160
1147
21
70
3.04
5.12
1.0
1.2
—
—
—
0
0
247
1876
1.41
5.11
4.1
3.1
1.15
1.08
e6/l
0.10
134
1050
16
36
4.50
5.06
1.9
2.4
0.59
0.61
mmol/l
0.40
16
36
921
8662
1.52
4.68
6.1
5.6
1.92
2.01
mu/l
1.49
878
7929
275
2159
1.37
4.62
1.4
1.3
0.90
1.49
u/ml
1.22
119
555
1014
9787
2.08
4.54
45.3
27.7
253.41
246.21
e9/l
2.55
1008
9585
88
550
1.65
4.53
1.6
1.5
—
—
—
0
0
1014
9788
2.08
4.52
45.9
28.2
39.50
39.92
%
2.47
1009
9673
1014
9788
2.08
4.52
45.2
27.7
7.11
6.76
e9/l
4.69
1005
9552
1014
9788
2.08
4.52
45.2
27.7
4.36
4.42
e12/l
3.92
1005
9550
58
322
1.85
4.51
1.3
1.6
—
—
—
0
0
78
473
1.70
4.50
2.5
2.8
2.74
2.99
g/l
1.50
72
429
142
994
1.50
4.49
4.1
2.8
4.54
4.44
kpa
0.19
135
963
393
3269
1.32
4.47
1.9
1.7
21.32
20.39
nmol/l
0.64
367
2716
1014
9791
2.07
4.47
45.6
27.9
130.17
133.50
g/l
10.71
1009
9680
24
97
2.51
4.15
1.5
1.2
—
—
—
0
0
555
4879
1.29
4.06
2.7
2.6
—
—
—
0
0
951
9054
1.54
4.03
6.4
5.7
6.23
6.04
mmol/l
3.93
915
8209
30
137
2.22
3.99
2.1
1.7
—
—
—
0
0
30
137
2.22
3.99
1.2
1.1
98.00
102.10
iu/ml
—
8
21
148
1071
1.44
3.95
2.5
2.7
69.85
70.80
e9/l
0.11
108
800
63
375
1.72
3.92
3.0
2.8
0.03
0.02
g/l
0.09
55
338
72
445
1.66
3.90
2.9
3.0
0.84
1.46
g/l
1.05
62
385
16
54
2.99
3.86
6.1
4.2
—
—
—
0
0
85
551
1.59
3.82
3.3
3.3
4.39
4.41
pmol/l
0.08
79
486
395
3348
1.29
3.75
2.6
2.3
170.46
219.83
u/l
0.68
381
3176
262
2104
1.33
3.70
4.2
4.2
252.14
368.56
ng/l
0.39
203
1749
213
1666
1.35
3.59
1.4
1.3
9.85
12.85
u/ml
0.30
108
581
22
92
2.42
3.57
1.2
1.4
0.45
0.35
nmol/l
0.16
13
66
102
701
1.50
3.54
1.8
1.7
—
—
—
0
0
78
506
1.59
3.51
2.5
2.8
3.48
3.76
g/l
1.21
72
463
78
507
1.58
3.48
2.5
2.8
4.16
4.21
g/l
0.22
72
463
78
507
1.58
3.48
2.5
2.8
7.40
7.42
g/l
0.04
72
463
224
1775
1.33
3.45
1.4
1.3
26.61
33.88
iu/ml
0.63
77
556
60
367
1.67
3.41
2.7
2.9
0.00
0.00
g/l
-0.00
44
323
18
70
2.60
3.39
1.4
1.5
—
—
—
0
0
41
227
1.84
3.28
1.7
1.8
49.12
42.43
nmol/l
0.29
41
214
17
66
2.60
3.22
1.4
1.5
—
—
—
0
0
21
91
2.33
3.18
1.3
1.6
—
—
—
0
0
15
55
2.75
3.16
2.1
2.0
—
—
—
0
0
29
147
2.00
3.02
2.1
1.7
—
—
—
0
0
535
4792
1.24
2.96
2.6
2.2
92.39
95.81
pmol/l
1.01
324
2484
77
521
1.52
2.91
2.3
4.0
27.07
105.20
u/ml
2.50
71
506
239
1954
1.29
2.91
3.6
3.6
0.76
0.75
ug/l
0.02
168
1359
10
27
3.73
2.88
1.4
1.9
1608.50
91.41
nmol/24h
—
10
27
35
193
1.84
2.87
2.1
1.8
—
—
—
0
0
63
409
1.57
2.87
2.5
2.9
—
—
—
0
0
11
33
3.36
2.81
1.1
1.3
16.91
11.15
mm/h
0.62
11
33
49
307
1.63
2.60
1.5
1.6
0.23
0.23
g/l
0.29
49
293
29
158
1.86
2.50
11.5
5.6
11.93
12.49
mg/l
0.34
29
147
9
26
3.48
2.48
2.0
1.1
2.48
3.83
umol/l
—
9
20
7
16
4.40
2.47
10.9
9.4
4.91
5.13
mmol/l
—
7
16
42
258
1.65
2.42
1.4
1.4
37.71
30.41
iu/l
0.63
33
219
45
285
1.60
2.31
1.8
1.7
—
—
—
0
0
28
155
1.83
2.31
1.1
1.1
—
—
—
0
0
13
53
2.47
2.28
1.8
1.4
17.98
23.32
umol/l
0.26
13
45
93
1238
0.73
2.28
13.1
7.6
—
—
—
0
0
17
79
2.17
2.25
1.4
1.4
—
—
—
0
0
156
1247
1.29
2.25
1.4
1.4
—
—
—
0
0
48
316
1.54
2.12
1.6
1.6
1.15
1.18
g/l
0.21
48
301
5
10
5.02
2.07
2.0
1.4
—
—
—
0
0
95
717
1.36
2.05
2.4
2.3
13.12
12.97
nmol/l
0.06
86
634
956
9275
1.35
2.02
6.8
6.4
2.45
2.62
mmol/l
7.74
909
8518
39
249
1.59
1.98
2.1
1.5
—
—
—
0
0
42
274
1.56
1.95
4.5
2.9
8.38
7.97
kpa
0.68
42
269
23
127
1.83
1.95
1.7
1.9
91.31
89.48
%
1.62
23
127
61
431
1.44
1.94
1.0
1.1
—
—
—
0
0
11
45
2.46
1.93
1.0
1.2
—
—
—
0
0
13
58
2.26
1.91
2.3
1.4
80.15
81.00
umol/l
0.06
13
58
0
52
0.00
1.88
0.0
2.5
—
—
—
0
0
8
28
2.87
1.86
1.1
1.1
92.53
138.82
iu/ml
—
8
28
17
86
1.99
1.85
1.0
1.0
286.76
292.66
mg/l
0.11
17
73
5
12
4.18
1.82
5.2
2.8
—
—
—
0
0
34
215
1.60
1.81
1.4
1.5
—
—
—
0
0
44
296
1.51
1.80
2.0
1.7
—
—
—
0
0
900
8689
1.25
1.79
4.8
4.6
1.33
1.29
mmol/l
1.30
847
7866
23
131
1.77
1.78
1.7
1.6
—
—
—
0
0
29
178
1.65
1.74
1.3
1.5
—
—
—
0
0
691
7283
0.85
1.72
36.8
24.2
330.26
331.42
g/l
2.61
685
7253
33
212
1.57
1.67
2.2
1.5
—
—
—
0
0
44
302
1.48
1.65
1.5
1.5
0.44
0.08
iu/ml
—
10
51
6
148
0.40
1.64
4.5
5.4
279.50
356.53
umol/l
—
6
136
33
495
0.66
1.61
1.5
1.8
3.62
3.46
mmol/l
0.31
22
370
112
899
1.28
1.60
6.7
3.8
81.16
90.62
ng/l
0.67
94
772
14
70
2.01
1.59
1.1
1.2
—
—
—
0
0
21
121
1.75
1.59
1.1
1.3
—
—
—
0
0
16
85
1.90
1.55
1.7
1.1
98.00
170.00
titre
—
5
15
49
673
0.71
1.51
1.9
2.1
3.51
3.42
ratio
0.24
37
546
15
79
1.91
1.50
1.8
1.3
6.43
0.65
u/ml
—
6
40
41
284
1.46
1.49
1.3
1.1
—
—
—
0
0
6
137
0.43
1.40
1.2
1.5
—
—
—
0
0
78
609
1.30
1.40
1.5
1.3
376.05
246.04
u/ml
0.22
71
558
6
139
0.43
1.40
1.2
1.5
—
—
—
0
0
12
224
0.53
1.39
1.3
1.3
—
—
—
0
0
30
198
1.53
1.38
1.4
1.3
111.43
475.38
titre
—
7
13
40
283
1.43
1.33
1.3
1.1
—
—
—
0
0
50
369
1.37
1.32
1.2
1.3
—
—
—
0
0
135
1137
1.22
1.29
6.9
3.5
1.54
1.92
mmol/l
0.63
123
970
359
3277
1.15
1.29
6.5
6.1
2.44
2.84
ug/l
0.49
331
2945
6
133
0.45
1.28
1.2
1.5
—
—
—
0
0
6
133
0.45
1.28
1.2
1.5
—
—
—
0
0
6
134
0.44
1.28
1.2
1.5
—
—
—
0
0
934
9116
1.22
1.26
5.9
5.5
4.39
4.55
mmol/l
5.61
886
8406
16
92
1.75
1.25
1.0
1.2
—
—
—
0
0
58
443
1.33
1.24
2.7
2.9
9.11
10.51
g/l
1.93
52
396
12
63
1.92
1.23
2.3
2.6
13.50
13.28
%
0.23
12
63
5
19
2.64
1.21
1.4
1.4
—
—
—
0
0
45
332
1.37
1.20
1.8
1.5
10.46
18.95
u/ml
—
5
54
31
214
1.46
1.19
1.3
1.4
—
—
—
0
0
31
214
1.46
1.19
1.3
1.4
—
—
—
0
0
6
26
2.31
1.19
1.0
1.0
—
—
—
0
0
47
351
1.35
1.17
1.3
1.6
0.32
0.33
mg/l
0.07
18
157
10
50
2.01
1.16
1.5
2.8
402.90
1135.70
u/ml
—
10
50
91
746
1.24
1.14
4.0
2.9
125.78
128.04
g/l
0.48
86
727
34
242
1.42
1.13
1.8
3.0
33.97
32.97
umol/l
0.07
29
216
7
30
2.34
1.12
1.6
3.3
7.43
6.20
ug/l
—
7
30
7
139
0.50
1.10
1.1
1.5
—
—
—
0
0
927
9063
1.20
1.09
5.7
5.4
1.45
1.47
mmol/l
1.04
875
8291
443
4136
1.12
1.08
2.2
2.0
1.36
1.33
mmol/l
0.27
386
3416
255
2300
1.14
1.08
4.8
4.5
1.02
1.02
kg/l
0.61
172
1569
13
216
0.60
1.05
1.2
1.1
—
4.57
—
0
23
20
130
1.55
1.03
2.6
3.9
—
—
—
0
0
19
122
1.57
1.03
1.4
1.4
56.33
61.69
%
0.22
12
77
39
290
1.36
1.02
3.0
3.4
2.36
2.12
index
0.12
25
157
40
300
1.35
1.00
1.3
1.5
—
—
—
0
0
109
926
1.20
0.99
1.6
1.8
1.64
1.56
%
0.34
90
770
31
224
1.40
0.97
1.2
1.2
24.16
52.65
u/ml
—
5
26
34
250
1.37
0.97
1.4
1.4
—
—
—
0
0
11
62
1.78
0.94
1.3
1.4
—
—
—
0
0
11
62
1.78
0.94
1.3
1.4
—
—
—
0
0
6
28
2.15
0.91
1.2
1.6
15.83
14.92
pmol/l
—
6
21
213
1924
1.13
0.89
2.0
1.8
1370.25
1190.93
nmol/l
2.03
167
1438
8
42
1.91
0.88
1.3
1.1
—
74.29
%
—
0
7
11
64
1.73
0.86
2.0
1.5
367.82
324.61
mu/l
0.28
11
49
11
64
1.73
0.86
4.1
3.3
0.91
0.91
index
0.01
11
64
69
826
0.82
0.82
1.7
1.5
—
—
—
0
0
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
18
123
1.47
0.78
1.0
1.2
2.13
6.36
u/ml
—
8
59
31
235
1.33
0.76
1.9
1.8
3.34
29.57
iu/l
0.52
14
92
51
414
1.24
0.76
2.0
1.8
6.87
8.26
iu/ml
0.22
22
103
35
271
1.30
0.75
3.0
2.2
129.61
127.58
g/l
0.17
28
217
64
535
1.21
0.73
3.1
3.1
26.19
25.25
mmol/l
1.30
59
516
32
246
1.31
0.72
1.7
1.6
—
—
—
0
0
139
1242
1.14
0.71
1.4
1.4
—
—
—
0
0
21
286
0.73
0.71
1.4
1.8
2.21
3.82
mg/l
1.14
15
228
18
126
1.44
0.70
2.0
1.8
15757.41
7296.48
u/l
—
9
38
5
28
1.79
0.66
1.4
1.8
—
—
—
0
0
16
112
1.44
0.63
1.0
1.1
115.69
116.07
%
0.01
16
103
106
940
1.14
0.62
2.4
2.5
5.15
6.76
ug/l
0.87
91
832
57
481
1.20
0.61
1.5
1.9
—
—
—
0
0
8
50
1.60
0.61
1.3
1.8
—
—
—
0
0
8
50
1.60
0.61
1.0
1.2
—
—
—
0
0
49
409
1.21
0.59
1.4
1.3
—
—
—
0
0
8
52
1.54
0.59
1.8
1.8
39.85
40.37
g/l
—
8
52
13
90
1.45
0.55
1.1
1.3
—
—
—
0
0
6
39
1.54
0.53
1.3
2.3
14.47
229.29
ug/l
—
6
33
16
215
0.74
0.53
1.6
1.5
—
—
—
0
0
6
41
1.47
0.50
1.2
1.1
—
—
—
0
0
52
446
1.17
0.49
1.4
1.8
—
—
—
0
0
64
565
1.14
0.43
1.3
1.2
76.25
135.43
u/ml
1.71
28
219
36
303
1.19
0.43
1.3
1.2
5.78
12.31
u/ml
—
6
13
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
0
17
0.00
0.40
0.0
2.7
—
—
—
0
0
5
34
1.47
0.40
1.0
1.2
—
21.33
u/ml
—
0
6
0
18
0.00
0.40
0.0
2.7
—
—
—
0
0
63
560
1.13
0.40
1.9
1.8
1.43
1.54
g/l
0.47
56
491
0
19
0.00
0.39
0.0
1.0
—
39.86
—
0
19
15
115
1.31
0.39
1.0
1.1
—
—
—
0
0
11
80
1.38
0.38
1.0
1.1
—
—
—
0
0
5
36
1.39
0.38
1.2
1.1
—
—
—
0
0
277
2645
1.06
0.38
4.8
5.0
22.21
21.36
%
0.43
150
1383
12
89
1.35
0.38
1.0
1.1
86.33
99.66
%
0.96
12
82
9
70
1.29
0.36
1.0
1.2
—
—
—
0
0
83
909
0.91
0.36
2.8
3.1
184.79
214.85
ng/l
0.29
75
841
6
42
1.43
0.35
4.8
1.8
—
—
—
0
0
14
108
1.30
0.35
2.2
2.8
—
—
—
0
0
10
134
0.74
0.35
1.6
1.4
6.12
6.45
mmol/l
—
10
124
10
73
1.37
0.34
1.1
1.1
3.57
2.06
mmol/l
—
10
68
6
88
0.68
0.33
1.0
1.5
—
27.00
—
0
10
33
285
1.16
0.32
2.2
1.6
8829.84
14304.67
e6/l
0.83
25
202
16
197
0.81
0.31
1.2
1.2
1.55
1.58
g/l
0.19
16
197
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
54
1.30
0.30
1.0
1.2
—
—
—
0
0
16
130
1.23
0.29
1.0
1.0
—
—
—
0
0
27
234
1.16
0.26
1.6
2.0
—
—
—
0
0
9
72
1.25
0.25
1.0
1.2
—
—
—
0
0
9
74
1.22
0.25
1.0
1.2
—
—
—
0
0
9
74
1.22
0.25
1.0
1.2
—
—
—
0
0
31
350
0.88
0.24
1.9
1.8
—
—
—
0
0
9
77
1.17
0.24
1.0
1.4
—
66.67
—
0
9
5
38
1.32
0.23
1.0
1.0
—
—
—
0
0
5
39
1.28
0.23
1.0
1.0
1988.20
1590.10
miu/ml
—
5
39
5
40
1.25
0.22
1.0
1.2
—
—
—
0
0
5
41
1.22
0.22
1.8
2.1
874.20
103.48
umol/l
—
5
27
5
42
1.19
0.21
1.2
1.1
1.02
1.07
ratio
—
5
34
0
10
0.00
0.21
0.0
1.5
—
8.80
—
0
5
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
6.9
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
6.04
—
0
12
8
102
0.78
0.21
1.5
1.2
—
90.88
—
0
8
11
89
1.24
0.21
1.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
10
122
0.82
0.19
2.4
6.7
7.32
7.20
mmol/l
—
10
99
12
100
1.20
0.18
4.0
1.8
—
—
—
0
0
7
61
1.15
0.17
1.0
1.7
—
—
—
0
0
35
381
0.92
0.16
1.8
2.0
—
—
—
0
0
30
273
1.10
0.16
2.2
2.5
86.63
80.27
ug/min
0.05
20
161
6
79
0.76
0.15
1.2
1.8
83.38
105.85
ng/l
—
6
79
9
81
1.11
0.15
1.0
1.4
—
418.57
—
0
7
9
81
1.11
0.15
1.1
1.4
13.67
13.61
u/l
—
9
75
15
131
1.15
0.14
1.9
1.4
58823.71
54484.87
e6/l
—
7
67
26
237
1.10
0.14
1.3
1.2
23.00
51.37
e6/l
0.47
19
179
29
267
1.09
0.13
2.4
3.6
0.75
0.81
nmol/l
0.37
24
220
10
85
1.18
0.12
1.1
1.0
—
—
—
0
0
17
153
1.11
0.11
1.8
1.4
2162.11
1695.10
e6/l
—
9
103
11
96
1.15
0.10
1.2
1.2
9.00
12.82
u/l
1.22
11
85
31
290
1.07
0.10
1.4
1.2
2.94
2.83
u/ml
—
7
27
31
290
1.07
0.10
1.4
1.2
1.68
7.33
u/ml
0.83
11
44
63
604
1.05
0.10
3.2
3.6
1.52
1.92
mmol/l
0.63
41
456
5
46
1.09
0.09
1.6
1.6
80.40
52.22
ug/l
—
5
46
6
55
1.09
0.09
2.3
3.2
1.17
1.16
%
—
6
55
23
214
1.08
0.08
1.8
1.2
0.89
0.91
g/l
0.12
23
214
6
58
1.03
0.08
1.0
1.1
—
—
—
0
0
7
66
1.06
0.08
1.7
1.8
—
—
—
0
0
9
88
1.02
0.07
1.0
1.0
—
—
—
0
0
9
100
0.90
0.06
1.1
1.5
—
—
—
0
0
9
100
0.90
0.06
1.1
1.5
—
—
—
0
0
9
100
0.90
0.06
1.1
1.5
—
—
—
0
0
18
191
0.94
0.04
1.4
1.9
—
—
—
0
0
16
150
1.07
0.04
1.3
1.1
—
24.20
—
0
5
34
329
1.03
0.03
1.1
1.4
—
—
—
0
0
10
108
0.93
0.03
1.5
1.9
—
—
—
0
0
11
117
0.94
0.01
1.5
1.8
—
—
—
0
0
10
106
0.94
0.01
1.1
1.1
—
—
—
0
0
30
306
0.98
0.00
2.1
1.3
—
—
—
0
0
10
96
1.04
0.00
1.1
1.1
—
—
—
0
0
11
108
1.02
0.00
1.5
1.2
—
—
—
0
0
19
185
1.03
0.00
1.2
1.3
269.40
210.75
miu/ml
—
5
77
0
6
0.00
0.00
0.0
1.5
—
2.50
—
0
6
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
5
52
0.96
-0.00
1.4
1.6
—
—
—
0
0
6
62
0.97
-0.00
1.2
1.0
—
—
—
0
0
5
50
1.00
-0.00
1.4
1.2
—
—
—
0
0
5
58
0.86
-0.00
1.6
1.7
75.46
62.65
ug/l
—
5
46
8
81
0.99
-0.00
2.1
1.3
44.40
32.19
u/l
—
8
63
6
59
1.02
-0.00
1.8
1.8
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_PANCREAS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_PANCREAS | 2.49 [2.03, 3.05] | < 0.001 |
| Birth year | 0.996 [0.99, 1.0] | 0.372 |
During the follow-up period (1.1.1998 — 31.12.2019), 488 out of 1662 females with CD2_BENIGN_PANCREAS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_PANCREAS | 3.362 [2.54, 4.46] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.011 |
During the follow-up period (1.1.1998 — 31.12.2019), 427 out of 1130 males with CD2_BENIGN_PANCREAS died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_PANCREAS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.271% | 0.774% |
| 5 | 1.715% | 4.164% |
| 10 | 4.112% | 9.607% |
| 15 | 7.39% | 17.252% |
| 20 | 12.905% | 28.711% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_PANCREAS – Benign neoplasm: Pancreas
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data